MRVI Stock Analysis: Buy, Sell, or Hold?

MRVI - Maravai LifeSciences Holdings, Inc. Class A Common Stock

PHARMACEUTICAL PREPARATIONS
$6.04
-0.11 (-1.79%) ▼
5d: -1.31%
30d: +25.05%
90d: +110.45%
HOLD
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 10, 2026

Get Alerted When MRVI Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 HOLD: MRVI shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: MRVI is currently trading at $6.04, which is considered extended relative to its 30-day fair value range of $4.69 to $5.83.

Technical Outlook: Technically, MRVI is in a strong uptrend. The price is approaching resistance at $5.21. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.

Market Sentiment: MRVI has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position EXTENDED
Historical Trading Range $4.69 - $5.83
Company Quality Score 58/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 55.3%

All Signals

  • BEARISH: Price extended above range
  • BULLISH: Strong technical setup (60/100)
  • BULLISH: High volume confirmation
  • BEARISH: Trading above Wall St target ($5.70)

Trading Range Analysis

30-Day Trading Range $4.69 - $5.83
Current vs Trading Range EXTENDED

Support & Resistance Levels

Support Level $4.34
Resistance Level $5.21
Current Trend Strong Uptrend
Technical data as of Jun 9, 2026

Fundamental Context

Forward P/E (Next Year Est.) -64.95
Wall Street Target $5.70 (-5.6%)
Revenue Growth (YoY) 40.5%
Earnings Growth (YoY) -32.7%
Profit Margin -51.1%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: July 03, 2026 1:46 AM ET
Data refreshes hourly during market hours. Next update: 2:46 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for MRVI.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ONC
BeiGene, Ltd.
STRONG BUY
24 analysts
$412 59 HOLD
INSM
Insmed Inc
STRONG BUY
21 analysts
$197 54 HOLD
VKTX
Viking Therapeutics Inc
STRONG BUY
19 analysts
$93 63 BUY
ACLX
Arcellx Inc
STRONG BUY
18 analysts
$113 57 HOLD
RCKT
Rocket Pharmaceuticals I…
STRONG BUY
18 analysts
$9 62 BUY

More Analysis for MRVI

MRVI Technical Chart MRVI Price Prediction MRVI Earnings Date MRVI Investment Advisor MRVI Fair Price Analyzer MRVI Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals